Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
John M. Mandrola, MD Musings from Mandrola
Chief Cardiology Correspondent. Clinical Electrophysiologist, Baptist Medical Associates, Louisville, Kentucky
Trials & Fibrillations with John Mandrola
Five Thoughts on the Damar Hamlin CollapseThe cardiac arrest of Buffalo Bills defensive back Damar Hamlin has led to speculation about commotio cordis and more, but one electrophysiologist sees an opportunity for education on CPR and AEDs.
theheart.org on Medscape, January 5, 2023
Mandrola’s Top 10 Cardiology Stories of 2022 A few dogmas felled, wins for meds, an exemplary trial, and clinical trends good and bad are covered in John Mandrola’s annual wrap up of cardiology stories for 2022.
theheart.org on Medscape, December 15, 2022
AHA 2022STRONG HF: More Beats Less After Discharge for Heart Failure Rapid uptitration of meds after hospitalization for decompensated HF was associated with a reduction in death or hospitalizations. Can health systems do the intense early management, asks John Mandrola, MD.
theheart.org on Medscape, November 8, 2022
AHA 2022Is Iron Replacement in Heart Failure Worth the Trouble? The data from IRONMAN don't persuade this cardiologist that the additional burden outpatient iron infusions would place on patients with heart failure and low iron are worth it.
theheart.org on Medscape, November 7, 2022
AHA 2022 HCTZ vs Chlorthalidone -- A Win for Practicing Doctors and Science In the Diuretic Comparison Project, hydrochlorothiazide held its own compared with chlorthalidone as first-line hypertension agent despite U.S. experts' preference for the latter -- a lesson for us all, writes John Mandrola, MD.
Who Decides What Is Medical Misinformation? A California law against COVID misinformation may have good intentions, but medicine is replete with consensus recommendations that end up being wrong.
Medscape, October 13, 2022
Why Is Vitamin D Hype So Impervious to Evidence?Low levels of vitamin D are linked to myriad health conditions, but supplements have never delivered in a randomized trial. Why aren't clinicians and patients persuaded by the data, asks John Mandrola, MD.
Medscape, February 17, 2022
This Doc Still Supports NP/PA Led Care … With CaveatsThe rise in nurse practitioner- and physician assistant-led care will not be undone, according to this doctor who sees it as a good thing as long as training and experience are not neglected.
Why Long COVID Worries MeResearchers and clinicians focused on long-haul COVID or postacute sequelae of SARS-CoV-2 infection should remember our oath to first, do no harm.
